Loading clinical trials...
Loading clinical trials...
A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergan
NCT05403710 · Hidradenitis Suppurativa, Hyperhidrosis
NCT06638827 · Hyperhidrosis Primary Focal Palms
NCT05102396 · Hyperhidrosis, Oxybutynin, and more
NCT05805696 · Dermatoses, Vestibulodynia, and more
NCT04159610 · Primary Axillary Hyperhidrosis
Portland, Oregon
Vancouver, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions